Fenazoxine hydrochloride MedChemExpress (MCE)

Product Name	nefopam hydrochloride
Synonyms	NAFOPAN HCL NEFOPAM HCL Nefopam HCl NEFOPAM HYDROCHLORIDE nefopam hydrochloride LABOTEST-BB LT00159839 BENZOXAZOCINE HYDROCHLORIDE Synonyms NAFOPAN HCL NEFOPAM HCL Nefopam HCl NEFOPAM HYDROCHLORIDE nefopam hydrochloride LABOTEST-BB LT00159839 BENZOXAZOCINE HYDROCHLORIDE 3,4,5,6-TETRAHYDRO-5-METHYL-1H-2,5-BENZOXAZOCINE HYDROCHLORIDE 3,4,5,6-tetrahydro-5-methyl-1-phenyl-1h-2,5-benzoxazocine hydrochloride 5-methyl-1-phenyl-3,4,5,6-tetrahydro-1H-2,5-benzoxazocin-5-ium chloride 3,4,5,6-TETRAHYDRO-5-METHYL-1-PHENYL-1H-2,5-BENZOXAZOCINE HYDROCHLORIDE 1H-2,5-Benzoxazocine, 3,4,5,6-tetrahydro-5-methyl-1-phenyl-, hydrochloride 3-methyl-7-phenyl-6-oxa-3-azabicyclo[6.4.0]dodeca-8,10,12-triene hydrochloride
CAS	23327-57-3
EINECS	245-585-5
Chemical Formula	C17H20ClNO
Molecular Weight	289.8
inchi	InChI=1/C17H19NO.ClH/c1-18-11-12-19-17(14-7-3-2-4-8-14)16-10-6-5-9-15(16)13-18;/h2-10,17H,11-13H2,1H3;1H
Package	10 mM * 1 mL;100 mg;500 mg;1 g
Price	Email to quote
Descriptions	Nefopam hydrochloride Nefopam hydrochloride MedChemExpress (MCE) HY-B1057 23327-57-3 Fenazoxine hydrochloride 99.92% 4°C, sealed storage, away from moisture In solvent : -80°C, 6 months Descriptions Nefopam hydrochloride Nefopam hydrochloride MedChemExpress (MCE) HY-B1057 23327-57-3 Fenazoxine hydrochloride 99.92% 4°C, sealed storage, away from moisture In solvent : -80°C, 6 months -20°C, 1 month (sealed storage, away from moisture) Room temperature in continental US may vary elsewhere. Nefopam hydrochloride (Fenazoxine hydrochloride) is a centrally-acting but non-opioid analgesic drug, for the relief of moderate to severe pain. Nefopam hydrochloride targets β-catenin protein level in mesenchymal cells in-vitro and in-vivo. Nefopam hydrochloride (Fenazoxine hydrochloride) is a non-opioid, non-steroidal, centrally acting analgesic drug that is derivative of the non-sedative benzoxazocine[1]. Constitutively elevated β-catenin leads to a delayed and fibrous fracture repair process, and Nefopam inhibits β-catenin mediated signaling during skin wound repair3]. \| \| \| \| \| \| \| \| \| \| [1]. Kim KH, et al. Rediscovery of nefopam for the treatment of neuropathic pain. Korean J Pain. 2014 Apr 27(2):103-11. [Content Brief] [2]. Baht GS, et al. Pharmacologically targeting beta-catenin for NF1 associated deficiencies in fracture repair. Bone. 2017 May 98:31-36. [Content Brief] [3]. Poon R, et al. A high throughput screen identifies Nefopam as targeting cell proliferation in β-catenin driven neoplastic and reactive fibroproliferative disorders. PLoS One. 2012 7(5):e37940. [Content Brief]
Last Update	2025-04-01 14:45:47

MedChemExpress (MCE) also provides

Thalidomide-4-O-C2-NH2

Category: Signaling Pathways
CAS: 2341840-99-9
Last Update: 2025-04-01 14:45:47

PPARα-MO-1

Category: Signaling Pathways
CAS: 810677-36-2
Last Update: 2025-04-01 14:45:47

Netupitant N-oxide

Category: Signaling Pathways
CAS: 910808-11-6
Last Update: 2025-04-01 14:45:47

MK-0812

Category: Signaling Pathways
CAS: 624733-88-6
Last Update: 2025-04-01 14:45:47

TS-011

Category: Signaling Pathways
CAS: 339071-18-0
Last Update: 2025-04-01 14:45:47

SCH 530348 sulfate

Category: Signaling Pathways
CAS: 705260-08-8
Last Update: 2025-04-01 14:45:47

BAG 956

Category: Signaling Pathways
CAS: 853910-02-8
Last Update: 2025-04-01 14:45:47

YM758

Category: Signaling Pathways
CAS: 312752-85-5
Last Update: 2025-04-01 14:45:47


Supplier Name	MedChemExpress (MCE)
Contact	sales
Tel	609-228-6898
Mobile	609-228-6898
QQ
Email	sales@medchemexpress.com; tech@medchemexpress.com
Website	https://www.medchemexpress.com/
Wechat

Request for quotation

Supplier Contact